Neural Stem Cell Origins and Parkinson's Hedgehog Signaling | Neuro Zoom

Added:

Skepticism of Adult Human Neurogenesis and Alternative Parkinson's Paradigms

While research into neural stem cell (NSC) quiescence and LRRK2-Hedgehog signaling offers hope for endogenous brain repair, a major counterpoint in neurobiology questions the translational viability of this approach. Some prominent studies argue that neurogenesis declines to undetectable levels in the adult human brain, unlike in rodent models. If adult humans lack a functional pool of endogenous NSCs, therapies aimed at manipulating NSC quiescence and reactivation may not be clinically feasible. Furthermore, critics of signaling-centric models of Parkinson's disease argue that therapeutic efforts are better directed toward combating alpha-synuclein aggregation (the prion-like propagation hypothesis), mitochondrial dysfunction, or chronic neuroinflammation. These alternative perspectives suggest that targeting endogenous stem cell niches or specific ciliogenesis pathways may be secondary to addressing the broader, systemic proteotoxic and inflammatory cascades that drive dopaminergic neuron degeneration.

Fundamentals of neural stem cell biology, including the concept of cellular quiescence (reversible growth arrest) versus active neurogenesis.
The pathophysiology of Parkinson's disease, specifically the progressive loss of dopaminergic neurons in the substantia nigra and the role of genetic factors.
Basic principles of signal transduction pathways, particularly how morphogens like Hedgehog (Hh) regulate cellular behavior and development.
An introduction to LRRK2 (Leucine-rich repeat kinase 2), including its kinase activity and its status as a major genetic risk factor for familial Parkinson's disease.
The cellular link between LRRK2 mutations, primary cilia defects, and impaired Hedgehog signaling in the brain.
Advanced therapeutic strategies in regenerative medicine, specifically using neural stem cell transplantation or endogenous stem cell activation to treat neurodegeneration.
The design and clinical trial status of small-molecule LRRK2 inhibitors as potential disease-modifying therapies for Parkinson's disease.
Epigenetic and transcriptional networks that govern neural stem cell fate determination, niche maintenance, and long-term brain plasticity.
575 views4likes1:17:16@neurozoomOriginal Release: 2022-08-23

Neural stem cells originate from distinct embryonic lineages rather than being randomly selected from embryonic pools; p57/Kip2 induces cell cycle quiescence which activates Notch signaling and sustains HEY1 expression for long-term stem cell maintenance, while LRKK2 mutations cause primary cilia loss in cholinergic interneurons of the dorsal striatum, disrupting Sonic Hedgehog-GDNF neuroprotective signaling and contributing to Parkinson's disease pathogenesis.